2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
2017 | Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study | ACTA RADIOLOGICA |
2021 | Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2016 | Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model | JOURNAL OF HEPATOLOGY |
2015 | Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Dise | GUT AND LIVER |
2021 | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
| GUT AND LIVER |
2009 | Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients | JOURNAL OF MEDICAL VIROLOGY |
2014 | Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
| GUT AND LIVER |
2012 | Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea
| WORLD JOURNAL OF GASTROENTEROLOGY |
2008 | Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2020 | Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
| CANCERS |
2020 | Hepatocellular Carcinoma Risk Steadily Persists Over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
2020 | High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis | JOURNAL OF VIRAL HEPATITIS |
2008 | High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels | JOURNAL OF VIRAL HEPATITIS |
2019 | High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2014 | Histological subclassification of cirrhosis can predict recurrence after | LIVER INTERNATIONAL |
2015 | Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3
| JOURNAL OF VIRAL HEPATITIS |
2021 | History and future of hepatitis B virus control in South Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | HKR3 Regulates Cell Cycle Through the Inhibition of hTERT in Hepatocellular Carcinoma Cell Lines
| JOURNAL OF CANCER |
2010 | How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2012 | How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements
| YONSEI MEDICAL JOURNAL |
2012 | How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage. | DIGESTIVE DISEASES |
2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
2023 | Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study
| CANCERS |
2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
2017 | Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2016 | Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease. | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis | HEPATOLOGY |
2021 | Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
| GUT AND LIVER |
2014 | Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
2014 | Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma. | LIVER INTERNATIONAL |
2015 | Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization | DIGESTIVE AND LIVER DISEASE |
2019 | Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study
| KOREAN JOURNAL OF RADIOLOGY |
2023 | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria
| CANCER RESEARCH AND TREATMENT |
2013 | Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
| PLOS ONE |
2016 | Knockdown of HIF-1a and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells | APOPTOSIS |
2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
2012 | Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir. | LIVER INTERNATIONAL |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. | ONCOLOGY |
2019 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
| GUT AND LIVER |
2017 | Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke | ATHEROSCLEROSIS |
2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
2009 | Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2012 | Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. | DIGESTIVE DISEASES AND SCIENCES |
2009 | Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis | LIVER INTERNATIONAL |
2014 | Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
| PLOS ONE |
2015 | Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis | LIVER INTERNATIONAL |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
2010 | Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
| ANTIVIRAL THERAPY |
2014 | Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir | LIVER INTERNATIONAL |
2005 | Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |